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Recent outbreaks in monkeys have proven that canine distemper virus (CDV) causes diseases in a wide
range of mammals. CDV uses SLAM and nectin4 as receptors to replicate in susceptible animals. Here,
we show that human nectin4, but not human SLAM, is fully functional as a CDV receptor. The CDV
Ac96I strain hardly replicated in nectin4-expressing human epithelial NCI-H358 cells, but readily
adapted to grow in them. Unsurprisingly, no amino acid change in the H protein was required for the
adaptation. The original Ac96I strain possessed a truncated C protein, and a subpopulation possessing
the intact C protein was selected after growth in NCI-H358 cells. Other CDV strains possessing the
intact C protein showed signiﬁcantly higher growth abilities in NCI-H358 cells than the Ac96I strain
with the truncated C protein. These ﬁndings suggest that the C protein is functional in human epithelial
cells and critical for CDV replication in them.
& 2012 Elsevier Inc. All rights reserved.Introduction
Distemper is an acute systemic infectious disease that mainly
affects dogs and other canidae, and is caused by canine distemper
virus (CDV) (Sawatsky et al., 2011). The disease is characterized
by fever, coughing, vomiting, diarrhea, and neurological manifes-
tations. CDV belongs to the genus Morbillivirus in the family
Paramyxoviridae. Measles virus (MV), rinderpest virus, phocine
distemper virus, Peste-des-petits-ruminants virus, and cetacean
morbillivirus also belong to the genus, and cause severe acute
systemic infections in humans, cows, seals, goats, and dolphins,
respectively (Wang et al., 2012). The host range of these viruses is
generally restricted to speciﬁc animal species. Recently, however,
animals of many species, Ailuridae (Kotani et al., 1989), Mustelidae
(Perpinan et al., 2008), Viverridae (Hirama et al., 2004; Hur et al.,
1999), Procyonidae (Roscoe, 1993), Phocidae (Osterhaus et al.,
1988), and Felidae (Appel et al., 1994; Roelke-Parker et al.,
1996), have been naturally infected with CDV. Importantly, in
the last several years, CDV has caused lethal outbreaks in nonhu-
man primates (Qiu et al., 2011; Sun et al., 2010).ll rights reserved.Viruses in the genus Morbillivirus are enveloped viruses that
possess a nonsegmented negative-stranded RNA genome encod-
ing six genes, N, P/V/C, M, F, H, and L (Wang et al., 2012).
The genome is encapsidated by the nucleocapsid (N) protein,
forming a helical ribonucleocapsid that is associated with a viral
RNA-dependent RNA polymerase composed of the phospho-
(P) and large (L) proteins. In addition to the P protein, the P gene
encodes two nonstructural proteins, V and C, by a process of RNA
editing and an alternative translation initiation in a different
reading frame, respectively (Wang et al., 2012). The V and C
proteins are non-essential products, but play important roles in
counteracting the host innate immune responses (Nakatsu et al.,
2008; Rothlisberger et al., 2010; von Messling et al., 2006). On the
envelope, there are two types of spike proteins, the hemagglutinin
(H) and fusion (F) proteins. The H protein is responsible for
receptor binding, while the F protein mediates membrane fusion
between the viral envelope and the host cell plasma membrane.
Both CDV and MV have been shown to use signaling lymphocyte
activation molecule (SLAM) and nectin4 as receptors (Muhlebach
et al., 2011; Noyce et al., 2011; Pratakpiriya et al., 2012; Seki et al.,
2003; Tatsuo et al., 2000). SLAM is expressed on a subset
of immune cells, while nectin4 is expressed at adherens junctions
in the epithelial tissues of various organs (Takeda et al., 2011).
Some neural cells in the central nervous system of dogs also
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(Pratakpiriya et al., 2012). Although morbilliviruses commonly
use SLAM as a receptor, each morbillivirus preferentially uses the
SLAM of its host animals (Seki et al., 2003; Tatsuo et al., 2001).
Tatsuo et al. (Tatsuo et al., 2001) reported that the HA7 strain of
CDV isolated using B95a cells, which express marmoset SLAM,
used human SLAM reasonably well, whereas the Onderstepoort
CDV vaccine strain failed to use it. In the present study, we
analyzed the ability of wild-type CDV strains to use human
nectin4 and human SLAM as receptors. In addition, the genetic
changes in CDV required for efﬁcient growth in human epithelial
cells were investigated.Fig. 1. Infection of the parental, nectin4-expressing, and SLAM-expressing Vero
cells with wild-type CDV strains. (A) Vero/hNectin4 (left panel) and Vero/dNectin4
(right panel) cells were stained with a goat anti-human nectin4 polyclonal
antibody (gray empty proﬁle) or a control goat IgG (ﬁlled black proﬁle), followed
by staining with Alexa Fluor 488-conjugated anti-goat IgG. (B) Vero, Vero/
hNectin4, Vero/dNectin4, Vero/hSLAM, and Vero.DogSLAMtag cells were infected
with wild-type CDV strains (Ac96I-VDS, 82Con, 55L, M24Cr, and Th12) or mock-
infected. At 48 h (Vero, Vero/hNectin4, Vero/dNectin4, and Vero/hSLAM) or 24 h
(Vero.DogSLAMtag) post-infection, the cells were stained with the Giemsa solu-
tion, and observed under a phase-contrast microscope. (C) Replication kinetics of
Ac96I. Vero/hNectin4, Vero/dNectin4, and parental Vero cells were infected with
Ac96I at a MOI of 0.01. At various time intervals post-infection, the virus titers
were determined by plaque assays.Results and discussion
Ability of wild-type CDV strains to use human nectin4 and human
SLAM as receptors
Our recent study showed that wild-type CDV strains use dog
nectin4 as a receptor (Pratakpiriya et al., 2012). A human nectin4
cDNA was obtained from human lung carcinoma-derived
NCI-H358 cells (Takeda et al., 2007), and Vero cells constitutively
expressing human nectin4 (Vero/hNectin4) were generated using
this cDNA. Flow cytometry analyses conﬁrmed that Vero/hNec-
tin4 cells expressed human nectin4, but the expression level was
several-fold lower than that of dog nectin4 in Vero/dNectin4 cells
(Pratakpiriya et al., 2012) (Fig. 1A). The MV H protein binds to the
V domain of human nectin4 (Muhlebach et al., 2011; Noyce et al.,
2011). We found six amino acid differences in the V domain
between human nectin4 and dog nectin4 (DDBJ/Gen Bank acces-
sion numbers AB755430 and AB755429, respectively) (Fig. 2).
The parental Vero, nectin4-expressing (Vero/dNectin4 (Pratakpiriya
et al., 2012) and Vero/hNectin4) and SLAM-expressing (Vero/hSLAM
(Ono et al., 2001) and Vero. DogSLAM tag (Seki et al., 2003)) Vero
cells were infected with wild-type CDV strains (Ac96I, 82Con, 55L,
M24Cr, and Th12). As reported previously (Pratakpiriya et al., 2012;
Seki et al., 2003), no syncytia developed in the parental Vero cells
infected with these CDV strains (Fig. 1B), although they may have
had low levels of infection without causing syncytium formation, as
shown for MV (Hashimoto et al., 2002). On the other hand, all the
strains produced large syncytia in Vero/hNectin4 cells as efﬁciently
as in Vero/dNectin4 cells (Fig. 1B). Syncytium formation was barely
detectable in Vero/hSLAM cells, but clearly evident in Vero.DogSLAM
tag cells (Fig. 1B). Thus, human SLAM seemed to be suboptimal as a
wild-type CDV receptor. The growth kinetics of Ac96I in the parental
Vero, Vero/dNectin4, and Vero/hNectin4 cells were analyzed. Ac96I
did not replicate in Vero cells, but showed efﬁcient replication in
both Vero/dNectin4 and Vero/hNectin4 cells (Fig. 1C). The replica-
tion kinetics in Vero/dNectin4 and Vero/hNectin4 cells were com-
parable with one another (Fig. 1C). To show the direct contribution
of the H protein to the syncytium formation, cell-to-cell fusion
assays were performed using mammalian cell expression vectors. In
all of the cell lines, no syncytia were observed when the F protein
was expressed alone (Fig. 3). When the H protein of Ac96I was
expressed together with the F protein, large syncytia developed in
Vero/hNectin4 and Vero/dNectin4 cells, but not in the parental
Vero cells (Fig. 3). The susceptibilities of Vero, Vero/dNectin4, and
Vero/hNectin4 cells to Ac96I infection were analyzed and compared.
The infectivity of Ac96I in Vero/hNectin4 cells determined by the
50% cell culture infectious dose (CCID50) was 4.2570.00 CCID50/ml,
which was comparable to that in Vero/dNectin4 cells (4.5870.12
CCID50/ml). The titer determined in Vero cells was less than 1.75
CCID50/ml. These data demonstrate that human nectin4 functions as
a CDV receptor as efﬁciently as dog nectin4, while human SLAM
does not.The pathology of morbilliviruses is well documented for MV.
MV is an airborne virus, and the infection starts via SLAM-
mediated entry into alveolar macrophages and dendritic cells in
the lung or respiratory tracts. After replicating in local lymph
nodes, MV spreads to various lymphoid organs or tissues through-
out the body using SLAM as a receptor (Takeda et al., 2011). Thus,
the ability to use SLAM is critical for MV, and probably for all
morbilliviruses, to spread and cause diseases in vivo. Conversely,
nectin4 is used at the late stage of infection to shed progeny
viruses into the respiratory tract (Takeda et al., 2011). Thus, the
low capacity for using human SLAM would explain the inability of
CDV to replicate in humans.
Potential of wild-type CDV strains to replicate in human epithelial
cells
The host range of MV is determined by not only receptors but
also intracellular factors (Iwasaki and Yanagi, 2011). NCI-H358
cells are highly susceptible and permissive to MV infection
(Takeda et al., 2007). NCI-H358 cells were found to express
human nectin4, although the expression level was signiﬁcantly
Fig. 2. Amino acid sequence comparison of the V domains of human, dog, and mouse nectin4. Dots indicate identical residues to those of human nectin4.
Fig. 3. Cell-to-cell fusion assays. Vero (left panels), Vero/hNectin4 (middle
panels), and Vero/dNectin4 (right panels) cells were transfected with the
mCherry-expressing plasmid and the F protein-expressing plasmid (upper panels)
or the mCherry-expressing plasmid and both the F protein-expressing plasmid
and H protein-expressing plasmid (bottom panels). At 48 h post-transfection, the
cells were observed using an Axio Observer.D1 microscope.
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MV replicates in these cells in a nectin4-dependent manner
(Muhlebach et al., 2011; Noyce et al., 2011). NCI-H358 cells were
infected with wild-type CDV strains (Ac96I, 82Con, 55L, M24Cr,
and Th12) at a multiplicity of infection (MOI) of 0.01, and the
infectious virus titers were determined at 5 days post-infection
(Fig. 4B). The data showed that the virus titer of the Ac96I strain
was signiﬁcantly lower than those of the other four wild-type
CDV strains (Fig. 4B). The Ac96I strain was originally isolated from
the large intestine of dogs with distemper using Vero.DogSLAM-
tag cells (Lan et al., 2006) and passaged 2–3 times in Vero.Dog-
SLAMtag cells to obtain a sufﬁcient amount of virus stocks for
analysis. In the following experiments, the Vero.DogSLAMtag cell-
grown Ac96I strain was designated Ac96I-VDS. NCI-H358 cells
were infected with Ac96I-VDS, and the virus titers were deter-
mined at 1, 3, 5, and 7 days post-infection (Fig. 4C). The results
conﬁrmed that Ac96I-VDS replicated poorly in NCI-H358 cells
(Fig. 4C). Nevertheless, at 7 days post-infection, some production
of infectious viruses was observed in Ac96I-infected NCI-H358
cells (Fig. 4C). After eight passages of Ac96I-VDS in NCI-H358
cells, the CDV-infected cells were scraped into culture medium,
subjected to three cycles of freezing-and-thawing, and centri-
fuged. The supernatants were collected. The NCI-H358 cell-grown
CDV was designated Ac96I-H358. Fresh monolayers of NCI-H358
cells were infected with Ac96I-H358, and the replication kinetics
were analyzed at various time intervals. The data showed that
Ac96I-H358 replicated well in NCI-H358 cells and produced
infectious virus particles efﬁciently (Fig. 4B). To conﬁrm the
growth ability of Ac96I-H358 in human epithelial cells, the
replication kinetics of Ac96I-VDS and Ac96I-H358 were analyzed
in another nectin4-positive human epithelial cell line, II-18
(Shirogane et al., 2010). Both Ac96I-VDS and Ac96I-H358 were
able to replicate in II-18 cells (Fig. 4D). However, the replication
ability of Ac96I-H358 was obviously greater than of Ac96I-VDS in
II-18 cells, as observed in NCI-H358 cells (Fig. 4C and D). These
ﬁndings conﬁrmed that Ac96I-H358 exhibits restored ability to
grow in human epithelial cells.Genetic changes in the Ac96I-H358 strain during propagation
in human epithelial NCI-H358 cells
Similar to other RNA viruses, CDV forms quasispecies.
The nucleotide sequences of Ac96I-VDS and Ac96I-H358 were
deeply analyzed by next-generation sequencing. Table 1 shows a
list of the nucleotide substitutions acquired by Ac96I-H358, as
well as selected preexisting nucleotides, during the eight passages
of Ac96I-H358 in NCI-H358 cells. All of the nucleotide positions
where more than 15% of the Ac96I-H358 genome acquired a
nucleotide substitution or the proportion of preexisting nucleo-
tides was increased by more than 15% are listed in Table 1.
Unsurprisingly, these data showed no amino acid change in the H
protein during the passages in NCI-H358 cells. These data
strengthen the above conclusion that the CDV H protein possesses
an intrinsic ability to use human nectin4 as a receptor. Our
previous data for other wild-type strains also demonstrated that
no amino acid changes occurred in the H protein during isolation
from tissues of dogs with distemper and passages in Vero.Dog-
SLAMtag cells (Lan et al., 2005a). Therefore, the ability to use
human nectin4 is an intrinsic phenotype of wild-type CDV strains.
The most striking change was observed in the P gene. The P gene
encodes a polymerase cofactor protein, P, and two nonstructural
proteins, C and V. Although the C and V proteins are nonessential
for virus replication in cultured cells, they play crucial roles in
counteracting the host innate immune responses (Devaux et al.,
2007; Nakatsu et al., 2008; Rothlisberger et al., 2010; von
Messling et al., 2006). The majority (91%) of Ac96I-VDS had a
thymine at nucleotide position 2198, producing a truncated C
protein, while the remaining 9% possessed the intact C protein
(Table 1). The truncated C protein had a nonsense mutation at
amino acid position 126 and became shorter by 49 amino acids,
compared with the intact C protein (the site of the authentic stop
codon was predicted by analyses of other wild-type CDV strains
and previously reported CDV sequences (Fig. 5) (Wang et al.,
2012)). The other four wild-type CDV strains (82Con, 55L, M24Cr,
and Th12) possessed the intact C protein (Fig. 5). For MV, a
truncation of the C protein at amino acid position 157 made the C
protein defective in its ability to counteract the host interferon
system (Nakatsu et al., 2008). The C protein sequence was
perfectly (100%) restored in Ac96I-H358 (Table 1). These ﬁndings
suggest that expression of the intact C protein was critical for
replication in NCI-H358 cells, but not in Vero.DogSLAMtag cells.
The nucleotide substitution in the P gene also caused a valine-to-
alanine substitution at amino acid position 133 in the P protein
(Table 1). P gene mutations accompanied by truncation or muta-
tions in the C protein are often observed in the genome of Vero
cell-grown MV strains (Miyajima et al., 2004; Takeda et al., 1998;
Takeuchi et al., 2000). Vero cells are defective in the production of
interferons (Chew et al., 2009; Emeny and Morgan, 1979), whereas
NCI-H358 cells possess a functional interferon system (Ikegame
et al., 2010). Thus, it is most likely that the truncation mutation for
the C protein in Ac96I-VDS occurred in Vero.DogSLAMtag cells,
rather than occurring in nature, since the C protein plays an
important role for CDV pathogenesis in vivo (von Messling et al.,
2006). Recently, Vero-based cell lines, e.g., Vero/hSLAM for MV,
Fig. 4. Replication kinetics in NCI-H358 cells. (A) NCI-H358 cells were stained with a goat anti-human nectin4 polyclonal antibody (gray empty proﬁle) or a control goat
IgG (ﬁlled black proﬁle), followed by staining with Alexa Fluor 488-conjugated anti-goat IgG. (B) NCI-H358 cells were infected with the Ac96I-VDS, 82Con, 55 L, M24Cr, or
Th12 CDV strains at a MOI of 0.01. At 5 days post-infection, the virus titers were determined by plaque assays. (C, D) NCI-H358 (C) and II-18 (D) cells were infected with
Ac96I-VDS or Ac96I-H358 at a MOI of 0.01. At 1, 3, 5, and 7 days post-infection, the virus titers were determined by plaque assays.
Table 1
Acquired and selected nucleotides during passages in NCI-H358 cells.
Ac-96I-VDS Ac-96I-H358
Proportion (%) Proportion (%)
Gene Nucleotide position Total no. of reads A C G T Total no. of reads A C G T Protein Amino acid
substitution
N 792 349 0 0 0 100 138 0 0 75a 25 N L229V
N 974 541 0 1 0 99 148 0 32 0 68 n.a.b no
N 995 340 0 0 0 100 116 0 0 43 57 N I296M
N 1506 100 0 0 100 0 33 18 0 82 0 N E467K
P/V/C 2198 1024 0 9 0 91 101 0 100 0 0 P and VC V133A 126Qc
M 3681 364 98 0 2 0 73 78 22 0 0 M T84P
M 3965 63 0 0 0 100 46 50 0 0 50 M F178L
M 4047 48 100 0 0 0 37 73 0 27 0 M N206D
M 4417 81 84 0 0 16 31 100 0 0 0 M L329Q
F 5926 196 0 78 22 1 61 0 100 0 0 F R331P
F 6074 167 26 0 74 0 37 97 0 3 0 n.a. no
L 9107 194 2 0 98 0 23 17 0 82 0 n.a. no
L 14271 39 72 0 28 0 50 100 0 0 0 L D1748N
a Acquired and selected nucleotides are underlined.
b Not applicable.
c A termination codon at position 126 was replaced with a glutamine residue.
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interferon-deﬁcient phenotype of Vero cells is an advantage for
virus isolation. However, it may lead to the selection of a minor
clone with a low ability to counteract the host innate immune
responses. In this regard, use of lymphocyte-based cell lines and
epithelial cell lines with a functional interferon system is advisable
for the isolation of viruses for pathogenesis studies. In either case,
our data showed that the P gene in the 9% population of Ac96I-
VDS, which became 100% dominant in Ac96I-H358 cells, encodedC and V proteins that were functional for counteracting the human
interferon system.
Although the C protein appears to play a critical role for CDV
replication in NCI-H358 cells, mutations in other genes or
proteins may contribute to the Ac96I-H358 growth in these cells,
since the virus titer of Ac96I-H358 at 5 days post-infection was
10-fold greater than those of the other wild-type CDV strains
possessing the intact C protein (Fig. 4B, C). The data obtained by
next-generation sequencing also showed that certain proportions
Fig. 5. Amino acid sequence comparison of the C protein. Dots indicate identical residues to the Ac96I-H358 strain. Bars indicate that there are no amino acid residues at
these positions.
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genes (Table 1). These substitutions were leucine-to-valine,
isoleucine-to-methionine, and glutamic acid-to-lysine at amino
acid positions 129, 296, and 467 (L129V, I296M, and E467K),
respectively, in the N protein, and threonine-to-proline, phenyla-
lanine-to-leucine, and asparagine-to-aspartic acid at amino acid
positions 84, 178, and 206 (T84P, F178L, and N206D), respec-
tively, in the M protein (Table 1). Some mutations in the M
protein of MV were shown to contribute to virus growth in
unnatural host cells (Dong et al., 2009; Miyajima et al., 2004;
Tahara et al., 2005, 2007). Therefore, it is of great interest to
evaluate whether mutations in the M and N proteins are critical
for CDV adaptation to be able to grow in human cells.
In addition, the M gene possessed a selected nonsynonymous
substitution at position 4417 and both the F and L genes of Ac96I-
H358 possessed a single selected nonsynonymous substitution
(L329Q, R331P, and D1748N in the M, F, and L proteins, respectively)
(Table 1). However, these mutations did not seem to be important for
CDV to acquire the capacity to replicate well in NCI-H358 cells, since
the major population (72–84%) of Ac96I-VDS already possessed
these substitutions (Table 1). Since CDV possesses a nonsegmented
RNA genome, some unnecessary mutations could be accompanied by
signiﬁcant changes, which exist on the same RNA genome.
Tatsuo et al. (2001) demonstrated that the CDV HA7 strain, but
not the Onderstepoort CDV vaccine strain, used human SLAM
reasonably well. However, our data showed that wild-type CDV
strains used human SLAM poorly, similar to the case for the
Onderstepoort vaccine strain. Since the HA7 strain was isolated
using marmoset SLAM-expressing B95a cells, it may have adapted
to use nonhuman primate SLAM as well as human SLAM. Thus,
the Onderstepoort vaccine strain, rather than the HA7 strain, may
have retained the original phenotype regarding the ability to use
human SLAM. The data for the HA7 strain described in Tatsuo
et al. (2001) may rather suggest that CDV easily adapts to the use
of human SLAM. Seki et al. (2003) demonstrated that only a few
amino acid changes in the H protein are sufﬁcient for wild-type
CDV strains to use marmoset SLAM efﬁciently, although they did
not examine whether these changes conferred the ability to use
human SLAM on the wild-type CDV strains. Unlike human SLAM,
human nectin4 was fully functional as a wild-type CDV receptor.
Despite this ability, Ac96I-VDS failed to spread in a human
epithelial cell line. However, this phenotype is unlikely to be
the original phenotype of wild-type CDV strains. Instead, theymay have an intrinsic potential to replicate in human cells. In
addition, the restoration of the C protein observed in the Ac96I-
H358 strain implies that the CDV C protein is capable of counter-
acting human innate immune responses. Indeed, the CDV strains
possessing the intact C protein showed reasonable degrees of
ability to replicate in human epithelial cells. Nevertheless, the
virus titers of these CDV strains in NCI-H358 cells were still lower
than that of MV (data not shown) (Takeda et al., 2007). Some
intracellular human host factors may not be optimal for the
CDV replication machinery. Importantly, the Ac96I-H358 strain,
which adapted to growth in NCI-H358 cells, showed a signiﬁ-
cantly higher replication potential than the other CDV strains in
NCI-H358 cells, and its growth ability approached that of MV.
The critical factors that create the species barrier of CDV
between susceptible animals and humans still remain unknown.
However, some CDV strains appear to have already adapted
to growth in nonhuman primates (Qiu et al., 2011; Sun et al.,
2010). CDV is closely related to MV, and the major structural
proteins of these viruses have some immunological cross-reactiv-
ity, such that immunity raised against MV proteins is partially,
but insufﬁciently, effective against CDV infection (Giraudon
and Wild, 1981; Norrby and Appel, 1980; Orvell and Norrby,
1980; Stephenson and ter Meulen, 1979; Taylor et al., 1991).
Furthermore, some viral proteins of CDV and MV are even
functionally exchangeable (Brown et al., 2005). The CDV genome
forms an active ribonucleocapsid complex with the N, P, and L
proteins of MV, and synthesizes viral RNAs using the MV proteins,
and vice versa (Brown et al., 2005). Thus, immunity against MV
may have protected humans against CDV infection. However,
based on the present experimental data and the observation of
large CDV outbreaks in monkeys (Qiu et al., 2011; Sun et al.,
2010), we suggest that CDV has sufﬁcient latent potential to adapt
to humans, and may cause a serious disease in humans in the
future. We thus propose that the preparation of a countermeasure
against CDV needs to be seriously considered at the present time.Materials and methods
Cells and viruses
Vero cells were maintained in DMEM supplemented with 5%
fetal bovine serum (FBS). Vero.DogSLAMtag, Vero/hSLAM, and
N. Otsuki et al. / Virology 435 (2013) 485–492490Vero/dNectin4 cells were reported previously (Pratakpiriya et al.,
2012; Seki et al., 2003) and maintained in DMEM supplemented
with 5% FBS and 1 mg/ml geneticin (G418; Invitrogen Life
Technologies, Carlsbad, CA). NCI-H358 cells (Takeda et al., 2007)
and II-18 cells (Shirogane et al., 2010) were maintained in RPMI
medium supplemented with 10% fetal calf serum. Total RNA
obtained from NCI-H358 cells was used to synthesize the cDNA
of human nectin4. The primers used for ampliﬁcation of the
human nectin4 cDNA were 50-GAATTCAGTCTGCCTTTCAACCA-30
and 50-GCGGCCGCAGGCAGGCCTGGGTCA-30 (sequences corre-
sponding to EcoRI and NotI sites are shown in italics). The human
nectin4 cDNA fragment was inserted into the pCXN2 vector,
generating pCXN2-hNectin4. A Vero cell clone stably expressing
human nectin4 (Vero/hNectin4) was generated by transfecting
Vero cells with pCXN2-hNectin4. Vero/hNectin4 cells were main-
tained in DMEM supplemented with 5% FBS and 1 mg/ml genet-
icin. The wild-type Ac96I strain of CDV was isolated from the
large intestine of dogs with distemper using Vero.DogSLAMtag
cells (Lan et al., 2006), and the working stock of the Ac96I strain,
which was passaged in Vero.DogSLAMtag cells 2–3 times in total,
was designated Ac96I-VDS. The other wild-type CDV strains
(82Con, 55L, M24Cr, and Th12) were isolated from morbid or
dead dogs with distemper using Vero.DogSLAMtag cells, and
reported previously (Lan et al., 2009; Lan et al., 2006; Lan et al.,
2005b). To obtain an NCI-H358 cell-adapted Ac96I strain, Ac96I-
VDS was inoculated into monolayers of NCI-H358 cells and
passaged eight times in these cells. After the eight passages, the
CDV-infected cells were scraped into culture medium, subjected
to three cycles of freezing-and-thawing, and centrifuged. The
supernatant was collected. The NCI-H358 cell-adapted Ac96I
strain was designated Ac96I-H358.Flow cytometry
The cell surface expression of nectin4 was analyzed using a
goat anti-human nectin4 polyclonal antibody (R&D Systems,
Minneapolis, MN) as the primary antibody and Alexa Fluor
488-conjugated anti-goat IgG (Molecular probes, Eugene, Oregon)
as the secondary antibody. Normal goat IgG (PEPROTECH, Rocky
Hill, NJ) was used as a control. The cell surface ﬂuorescence of
1104 cells was analyzed using a FACSCalibur ﬂow cytometer
(Becton Dickinson, Franklin Lakes, NJ).Replication kinetics
Monolayers of Vero, Vero.DogSLAMtag, Vero/dNectin4, and
NCI-H358 cells in 24-well plates were infected with Ac96I-VDS
or Ac96I-H358 at a MOI of 0.01 per cell. After various time
intervals, the cells were scraped into the culture supernatants,
and the virus titers (PFU) were determined by plaque assays in
Vero.DogSLAMtag cells.Plaque titration
Monolayers of Vero.DogSLAMtag cells in 6-well cluster plates
were infected with serially diluted virus samples, incubated for
1 h at 37 1C, and overlaid with 3 ml of minimal essential medium
containing 2% FBS and 0.8% agarose (0.8% agarose-MEM).
At 7 days post-infection, 2 ml of 0.8% agarose-MEM containing
0.01% neutral red was overlaid on each well, and the PFU was
determined by counting the number of plaques at 2 days after the
procedure.Cell susceptibility to CDV infection
To analyze the susceptibility of Vero, Vero/dNectin4, and Vero/
hNectin4 cells to Ac96I-VDS infection, serially diluted virus
samples were inoculated into monolayers of these cells, and the
CCID50 of Ac96I-VDS in these cells was determined.
Cell-to-cell fusion assay
DNA fragments encoding the H protein of Ac96I-VDS and the
CDV F protein were ampliﬁed and cloned into the pCAGGS vector.
Vero, Vero/dNectin4, and Vero/hNectin4 cells were seeded in
12-well plates, and transfected with the F protein-expressing
plasmid (0.3 mg) with or without the H protein-expressing plas-
mid (0.3 mg) using the TransIT-LT1 reagent (Mirus Bio, Madison,
WI). To clearly detect syncytia, a ﬂuorescent protein-expressing
plasmid (pCA7-FR-mCherry; 0.3 mg) was included into the trans-
fection mixture, as reported previously (Seki et al., 2011). At 48 h
post-transfection, the cell monolayers were observed using an
Axio Observer.D1 microscope.
Next-generation sequencing
Culture supernatants of Vero.DogSLAMtag and NCI-H358 cells
infected with Ac96I-VDS and Ac96I-H358, respectively, were
collected, and the virus particles were centrifuged into pellets
through 30% sucrose cushions (30% sucrose [wt/vol] in NTE [0.1 M
NaCl, 0.01 M Tris pH 7.4, 0.001 M EDTA]) at 185,000 g for 2 h in
a Beckman 45 Ti rotor at 4 1C. Subsequently, viral RNA was
puriﬁed from the virus particles using Isogen (Nippon Gene,
Tokyo, Japan). An RNAseq library was prepared using a Script-
SeqTM v2 RNA-Seq Library Preparation Kit (Illumina-compatible)
(Epicentre Biotechnologies, Madison, WI) and the indexing
method. Deep sequencing runs for pair-end short reads were
performed with MiSeq and GAIIx systems (Illumina, San Diego,
CA). To identify nucleotide variations based on the RNAseq
analysis, the obtained short reads were mapped to the corre-
sponding reference CDV genome sequence (Ac96I-VDS) by the
BWA mapping tool (Li and Durbin, 2010). The obtained mapping
data were visualized with GenomeJack viewer software (Mitsu-
bishi Space Software, Tokyo, Japan).
Sequencing of the P gene of CDV strains
Viral RNAs were extracted from each virus stock using a High
Pure Viral RNA Kit (Roche Diagnostics GmbH, Mannheim,
Germany) according to the manufacturer’s instructions. First-
strand cDNA was synthesized using Super ScriptIII reverse tran-
scriptase (Invitrogen, Carlsbad, CA), and then ampliﬁed by PCR
using Prime STAR GXL DNA polymerase (Takara Bio, Shiga, Japan).
The primers used for ampliﬁcation and sequencing are available
upon request. The PCR products were puriﬁed using a QIAquick
Gel Extraction Kit (Qiagen KK, Tokyo, Japan). The nucleotide
sequences of the puriﬁed PCR products were determined using
a Big Dye Terminator v3.1 Cycle Sequencing Kit (Applied Biosys-
tems, Foster City, CA) and a capillary sequencer.
Nucleotide sequence accession numbers
The short reads obtained by the next-generation sequencing
have been deposited in the DDBJ Sequence Read Archive (DRA) of
Japan (accession number: DRA000586). The consensus genome
nucleotide sequences of Ac96I-VDS and Ac96I-H358 have been
deposited in DDBJ/GenBank with accession numbers AB753775
and AB753776, respectively. The nucleotide sequences for the P
gene of 55L, Th12, M24Cr, and 82Con have been deposited in
N. Otsuki et al. / Virology 435 (2013) 485–492 491DDBJ/GenBank with accession numbers AB755425, AB755426,
AB755427, and AB155428, respectively.Acknowledgments
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